Sean McCutcheon
Stock Analyst at Raymond James
(3.94)
# 1,742
Out of 4,356 analysts
39
Total ratings
39.3%
Success rate
21.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Maintained: Buy | $19 → $26 | $14.05 | +85.05% | 2 | May 19, 2026 | |
| ENGN enGene Therapeutics | Maintained: Buy | $27 → $4 | $1.85 | +116.22% | 5 | May 8, 2026 | |
| CMPX Compass Therapeutics | Downgraded: Hold | n/a | $2.38 | - | 3 | Apr 28, 2026 | |
| VIR Vir Biotechnology | Maintained: Buy | $12 → $19 | $9.54 | +99.16% | 4 | Feb 24, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Initiated Coverage: Buy | $24 | $8.97 | +167.56% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $72 → $76 | $157.48 | -51.74% | 2 | Oct 17, 2025 | |
| BDTX Black Diamond Therapeutics | Maintained: Buy | $11 | $2.22 | +395.50% | 2 | Sep 10, 2025 | |
| RGNX REGENXBIO | Reiterated: Buy | $29 | $7.01 | +313.69% | 5 | Sep 5, 2025 | |
| XNCR Xencor | Maintained: Buy | $40 | $11.88 | +236.70% | 1 | Aug 7, 2025 | |
| LKFT Lakefront Biotherapeutics NV | Reiterated: Hold | n/a | $28.38 | - | 4 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $57.18 | - | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $614.78 | - | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $65 | $14.59 | +345.51% | 1 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 | $27.16 | +216.64% | 3 | Jun 13, 2025 |
Relay Therapeutics
May 19, 2026
Maintained: Buy
Price Target: $19 → $26
Current: $14.05
Upside: +85.05%
enGene Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $27 → $4
Current: $1.85
Upside: +116.22%
Compass Therapeutics
Apr 28, 2026
Downgraded: Hold
Price Target: n/a
Current: $2.38
Upside: -
Vir Biotechnology
Feb 24, 2026
Maintained: Buy
Price Target: $12 → $19
Current: $9.54
Upside: +99.16%
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $8.97
Upside: +167.56%
Revolution Medicines
Oct 17, 2025
Maintained: Buy
Price Target: $72 → $76
Current: $157.48
Upside: -51.74%
Black Diamond Therapeutics
Sep 10, 2025
Maintained: Buy
Price Target: $11
Current: $2.22
Upside: +395.50%
REGENXBIO
Sep 5, 2025
Reiterated: Buy
Price Target: $29
Current: $7.01
Upside: +313.69%
Xencor
Aug 7, 2025
Maintained: Buy
Price Target: $40
Current: $11.88
Upside: +236.70%
Lakefront Biotherapeutics NV
Jul 24, 2025
Reiterated: Hold
Price Target: n/a
Current: $28.38
Upside: -
Jul 17, 2025
Maintained: Hold
Price Target: n/a
Current: $57.18
Upside: -
Jul 17, 2025
Maintained: Hold
Price Target: n/a
Current: $614.78
Upside: -
Jul 11, 2025
Initiated Coverage: Buy
Price Target: $65
Current: $14.59
Upside: +345.51%
Jun 13, 2025
Maintained: Buy
Price Target: $86
Current: $27.16
Upside: +216.64%